(2025) in Nature Cardiovascular Research documented 100% 3-year and 5-year survival in tricaprin-treated TGCV heart failure patients compared to 78.6% and 68.1% in controls
For triathletes who are using (or considering using) GLP-1 medications for any reason, it is important to understand how they may affect training, fueling strategies, and recovery, as well as evolving regulatory considerations
The Mechanics of Subcutaneous Injections To understand why a shot might hurt more on some days than others, we must first look at how the medication enters the body
Tirzepatide functions as an imbalanced dual agonist, characterised by a molecular structure exhibiting a markedly higher affinity for the GIP receptor than the GLP-1 receptor
Comprehensive Assessment: Your Foundation for Success Before initiating any semaglutide treatment, or considering a modified dosing schedule, a licensed healthcare provider conducts a thorough evaluation
Metabolic diseases The incidence of all metabolic diseases increased from 2000 to 2019, according to data from the World Health Organization (WHO)
